This article was written by Follow Samuel Smith has a diverse background that includes being lead analyst and Vice President at several highly regarded...
This article was written by Follow Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish...
By Adila McHich, Cameron Liao, Elizabeth Hui and Paul Wightman At a Glance From natural gas supply and demand dynamics to OPEC+ decisions, heightened...
Listen on the go! Subscribe to Wall Street Breakfast on Apple Podcasts and Spotify This is an abridged conversation from Seeking Alpha’s Investing Experts...
Co-authored with “Hidden Opportunities.” The U.S. economy continues to slow down as the Federal Reserve continues its inflation containment efforts. While rates have been...
As fears about Beijing’s potential invasion of Taiwan once again gain traction and prompt investors like Warren Buffett to unwind their long positions in...
Kinnate Biopharma (NASDAQ:KNTE) develops small molecule kinase inhibitors to treat genomically defined cancers. The company has two molecules in the clinic, exarafenib and KIN-3248....
Having a good investment philosophy matters as much as picking the “right” stocks. That’s because even dominant companies can fall on hard times due...
She doesn’t know how much her student-loan bill will be when the years-long pandemic-era freeze on payments ends. Eminger’s loans were transferred during the...